FNIH Trailblazer Prize for Clinician-Scientists

2018 FNIH Trailblazer Prize for Clinician-Scientist

Overview

In 2018, the Foundation for the National Institutes of Health (FNIH) will present the FNIH Trailblazer Prize for Clinician-Scientists (Trailblazer Prize), which recognizes the outstanding contributions of early career clinician-scientists whose work has the potential to or has led to innovations in patient care. This $10,000 honorarium and prize celebrates the achievements of medical doctors whose research has translated basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability. The prize, made possible by an anonymous donation, will be presented at the FNIH Annual Fall Board Dinner on October 24, 2018 in Washington, D.C.

The FNIH recognizes the unique and critical role that clinician-scientists play in the evolution of medical practice. As noted in the 2014 NIH Physician-Scientist Workforce Report, these individuals play a vital role in ensuring that biomedical advances ultimately benefit patients and improve population health. Through the Trailblazer Prize, the FNIH celebrates the transformational work of clinician-scientists, whose research translates basic scientific observations into new paradigm-shifting approaches for diagnosing, preventing, treating or curing disease and disability.

The awardee will be selected by a jury of distinguished clinical-scientists including:

  • Steven M. Paul, M.D., (Jury Chair), Venture Partner at Third Rock Ventures
  • Barry Coller, M.D., David Rockefeller Professor of Medicine, Head of the Allen and Frances Adler Laboratory of Blood and Vascular Biology, Physician-in-Chief of the Rockefeller University Hospital, Vice President for Medical Affairs, The Rockefeller University
  • Helen H. Hobbs, M.D., Investigator, Howard Hughes Medical Institute and Professor of Internal Medicine and Molecular Genetics, University of Texas Southwestern Medical Center
  • John I. Gallin, M.D., NIH Associate Director for Clinical Research and Chief Scientific Officer of the NIH Clinical Center
  • Michael J. Welsh, M.D., Director, Pappajohn Biomedical Institute, University of Iowa

Nominators and/or candidates must not contact any member of the Trailblazer Prize jury to ask about or discuss any aspect of the prize. If this occurs, that nomination will be withdrawn from the competition.

2018 Prize Nominations

The FNIH has selected three finalists for the Trailblazer Prize. The recipient of the prize will be announced in the fall of 2018.

Contact

Please email TrailblazerPrize@fnih.org with questions.